JNJ

Johnson & Johnson
D

JNJ

147.060
USD
-0.74
(-0.50%)
Market Closed
Volume
286,400
EPS
11
Div Yield
3.32
P/E
24
Market Cap
354,065,034,262
Signals
Related Instruments
    ABBV
    ABBV
    -2.210
    (-1.27%)
    171.520 USD
    ABT
    ABT
    -0.420
    (-0.37%)
    113.490 USD
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    BMY
    BMY
    -0.100
    (-0.18%)
    56.300 USD
    GSK
    GSK
    -0.035
    (-0.10%)
    33.430 USD
    LLY
    LLY
    -32.08
    (-4.23%)
    726.07 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    NVS
    NVS
    -0.320
    (-0.33%)
    97.530 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    SYK
    SYK
    1.63
    (0.43%)
    383.42 USD
    More
News

Title: Johnson & Johnson

Sector: Healthcare
Industry: Drug Manufacturers - General
Johnson & Johnson is an American multinational corporation founded in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. The company’s ethos is centered around good health as the foundation of vibrant lives. Since its inception, it has continued this mission and is now considered the world’s largest and most broadly based healthcare company, with more than 140,000 employees around the world. The company develops medical devices, pharmaceuticals, and consumer packaged goods. It features prominently in the top 50 of the Fortune 500 list of corporations by total revenue. The company is headquartered in New Brunswick, New Jersey. Its holdings include some 250 subsidiary companies with operations in 60 countries and products sold in over 175 nations. Among its best-known brand assets are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin products, and more.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.